NEIL3 and hepatocellular carcinoma: Subgroup analysis showed that patients with high NEIL3 levels had significantly shorter OS and DFS than those with low NEIL3 levels in HCC patients with advanced TNM stage, hypofractionated tumors, HBsAg-positive or cirrhotic liver [65] (Table 1).